GLP-1 Cost Without Insurance: What You’ll Pay

GLP 1 drugs can cost more than $1,000 a month at list price. That number stops a lot of people from even starting conversation with their doctor. But actual amount you pay depends on your insurance, which drug your doctor prescribes, and whether you know where to find savings programs.

The pricing picture for GLP 1 drugs has shifted over past year. Manufacturers have cut direct to consumer prices. Medicare is beginning to cover these drugs for weight loss for first time. And compounded versions, while harder to find than they were in 2024, are still available through licensed pharmacies at lower cost points. Here's what each drug actually costs right now, what your insurance may or may not cover, and how to bring your out of pocket spending down.

How much do GLP 1 drugs cost in 2026?

The list price for most brand name GLP 1 drugs still sits above $900 per month. That's sticker price pharmacies use before insurance, coupons, or manufacturer programs are applied. Very few people actually pay that full amount.

Here's where main drugs stand right now:

• Semaglutide injections (Ozempic, Wegovy): list price around $935 to $1,349 per month. Direct to consumer pricing from Novo Nordisk has brought certain Wegovy doses down to $149 to $199 per month for self pay patients.
  
  

• Tirzepatide injections (Mounjaro, Zepbound): list price around $1,060 per month. Eli Lilly's self pay vial program starts at $299 for lowest dose and goes up to $499 for highest.
  
  

• Liraglutide (Saxenda): list price around $1,400 per month. Fewer discount programs exist for this one compared to newer GLP 1s.
  
  

• Dulaglutide (Trulicity): list price around $1,000 per month. Eli Lilly has brought it to $389 per month through certain programs.
  
  

• Orforglipron (Foundayo): newest oral GLP 1, entering market at $149 per month through select programs.

These numbers shift frequently. What you actually see at the pharmacy counter depends on your plan, your diagnosis, and whether prior authorization has been filed.

What is cheapest GLP 1 without insurance?

If you don't have insurance or your plan doesn't cover these drugs, manufacturer direct to consumer programs have become most straightforward route.

Wegovy is currently one of more affordable brand name options for self pay patients. Novo Nordisk's direct pharmacy program offers certain doses starting at $149 per month. Zepbound vials start at $299 per month through Eli Lilly's self pay program. And Foundayo (orforglipron), new oral option, launches at $149 per month.

Compounded semaglutide has been another path for people paying out of pocket. Throughout 2024 and early 2025, compounded versions were widely available through licensed 503A pharmacies for $99 to $269 per month. That picture has tightened in 2026 as FDA has narrowed legal basis for some compounders, but legitimate sources still exist through pharmacies with proper licensing and sterile compounding certifications.

The full GLP 1 cost without insurance isn't just drug itself. You're also paying for prescribing visit (usually $100 to $250 through telehealth), any required blood work like an A1C or metabolic panel ($50 to $200 at a cash pay lab), and follow up appointments every one to three months. When you add those up, even cheapest GLP 1 without insurance runs closer to $200 to $400 per month total, depending on drug and dose. That's still a fraction of $1,000+ list price, but it's more than drug cost alone suggests.

How much does a GLP 1 cost with insurance?

With commercial insurance, your cost depends on your plan's formulary and your diagnosis. Some plans cover GLP 1 drugs with a copay of $25 to $75 per month when prescribed for type 2 diabetes. Others don't cover them at all, or require a long prior authorization process first.

The biggest factor is why you're taking drug. Most commercial plans cover GLP 1s for type 2 diabetes with relatively little friction. Coverage for obesity alone is patchier. Some plans require a BMI above 30 (or above 27 with a condition like high blood pressure or high cholesterol) and documented evidence that diet and exercise alone didn't produce enough results.

If your plan covers drug but your copay is still high, manufacturer savings cards can bring it down further. More on those below.

Whether your insurer is BCBS or another commercial carrier, simplest first step is to call number on back of your insurance card and ask directly. Ask whether your specific GLP 1 drug is covered, for your specific diagnosis, and what copay would be.

Does Medicare cover GLP 1 drugs?

This is where things have changed most in past year. Historically, Medicare Part D covered GLP 1 drugs only when prescribed for type 2 diabetes, cardiovascular disease, or obstructive sleep apnea. Coverage for weight loss alone was excluded by law.

That's changing now. In late 2025, Trump administration announced pricing deals with Eli Lilly and Novo Nordisk that set Medicare prices for injectable GLP 1s at $245 per month across all doses. Starting in July 2026, Medicare GLP 1 Bridge program will give eligible Part D beneficiaries access to Wegovy and Zepbound for obesity treatment at a $50 copay per month. This bridge program runs through December 2027, after which the longer term BALANCE Modelwill determine whether Part D plans continue covering these drugs for weight management.

If you're on Medicare and wondering whether Medicare covers Mounjaro for your situation, answer depends on your diagnosis. For type 2 diabetes, Mounjaro may already be on your plan's formulary. For obesity alone, you'll need to wait for the GLP 1 Bridge program. To qualify for bridge, you'll need your doctor to submit a prior authorization, and you'll need to be enrolled in a Part D plan or a Medicare Advantage plan that includes drug coverage.

One thing to keep in mind: $50 copay under GLP 1 Bridge won't count toward your Part D deductible or $2,100 annual out of pocket spending cap. It runs as a separate program, not through your regular Part D benefit. That means your other drug costs won't be affected, but you also won't build toward your cap through these purchases.

Medicaid coverage is even more variable. As of early 2026, only 13 state Medicaid programs cover GLP 1 drugs for obesity. That number has actually dropped from 16 states in late 2025, as several states cut coverage due to budget pressures. Coverage rules and prior authorization requirements differ by state, and a KFF analysis tracks current state by state picture.

Are there savings cards or discount programs?

Yes, and they can reduce your cost sharply. Both Novo Nordisk and Eli Lilly run manufacturer savings card programs for commercially insured patients that can bring monthly costs down to $0 to $25 in eligible cases.

Here's where to start depending on your drug:

• If you're on Ozempic, Novo Nordisk's Ozempic savings card can reduce your copay to as low as $25 per month for eligible commercially insured patients.

• For Mounjaro, Eli Lilly runs a Mounjaro savings card with similar copay reduction.

• If you've heard about getting Mounjaro for $25 without insurance, that typically refers to Eli Lilly's self pay program for Zepbound vials rather than Mounjaro itself, though two get confused often.

These cards don't work with Medicare, Medicaid, or other government insurance. They're built for people with commercial plans, and eligibility terms can shift each calendar year.

How do GLP 1 drug costs compare to each other?

Not all GLP 1 drugs cost same, and gap has widened as manufacturers have rolled out different pricing strategies for different drugs.

At brand name level, Mounjaro vs Ozempic cost is one of most common comparisons people look up. Both have similar list prices above $900 per month, but out of pocket cost depends on which savings programs you qualify for and where each drug sits on your plan's formulary.

Tirzepatide vs Ozempic cost is same comparison using generic drug names. The pricing dynamics are identical.

For newer weight loss specific options, Zepbound vs Wegovy cost is another frequent question. Zepbound's self pay vial program starts at $299 while Wegovy's current direct pricing starts at $149 for lower doses, rising to $199 for higher ones.

For people who want absolute lowest retail price on a brand name GLP 1, Ozempic cost at Costco without insuranceis a question that comes up often. Warehouse pharmacies tend to offer slightly lower cash prices than standard retail chains, though manufacturer programs may still beat them.

Are GLP 1 pills cheaper than injections?

Right now, main FDA approved oral GLP 1 is Rybelsus (oral semaglutide), approved for type 2 diabetes. Its list price is similar to injectable semaglutide, so pill form doesn't automatically mean savings.

The new oral drug Foundayo (orforglipron) enters market at $149 per month through certain programs. That's a notable drop, because it's first oral GLP 1 priced below injections at launch. As more oral GLP 1s clear late stage trials and reach market, GLP 1 pill cost comparison will shift. Right now Rybelsus and Foundayo are only two options, and Foundayo is clearly cheaper one. But if even one more competitor enters at a similar price, that puts real downward pressure on whole category.

Will GLP 1 drug prices keep dropping?

The trend over past year has moved downward, driven by three forces: manufacturer competition, government pricing negotiations, and public pressure.

The Trump administration's Most Favored Nation pricing agreements set Medicare and Medicaid prices for GLP 1 injectables at $245 per month. The TrumpRx platform aims to sell these drugs at roughly $350 per month for vials. Semaglutide is also part of next round of Medicare drug price negotiations under Inflation Reduction Act, with new negotiated prices expected to take effect in 2027.

Competition is also increasing. Orforglipron entered as a pill priced below injections. Other next generation compounds like amycretin are in late stage clinical trials. When more drugs enter same market, that tends to push pricing down across board.

For now, though, practical reality is that your personal GLP 1 cost still depends on your insurance, your diagnosis, and how actively you pursue savings programs available to you.

How can you start paying less for your GLP 1 right now?

The fastest route depends on which bucket you fall into, so here's what actually works for each one.

If you have commercial insurance but your copay is high, manufacturer savings card is almost always first move. Novo Nordisk's card for Ozempic and Wegovy and Eli Lilly's card for Mounjaro and Zepbound can both bring a $200 to $400 copay down to $25 or less. You apply online, get a virtual card within minutes, and hand it to your pharmacist at pickup. One thing most people don't know: if your pharmacy runs savings card and it still comes back with a high price, ask them to run it again with drug's specific NDC number. Some pharmacies default to a different package size that card doesn't cover, and a simple resubmission fixes it.

If your plan denied coverage entirely, don't stop there. About 40% of GLP 1 prior authorization denials get overturned on appeal, and most common reason they fail first time is incomplete paperwork, not ineligibility. Ask your doctor's office to resubmit with your full BMI history, lab results, and documentation of previous weight loss attempts. Some offices have staff dedicated to prior authorizations, and others don't. If yours doesn't, ask your pharmacist whether they offer prior authorization support.

If you don't have insurance at all, go directly to manufacturer's self pay program before you try a third party telehealth company. Wegovy's direct program at $149 per month and Zepbound's vial program at $299 per month are often cheaper than what telehealth platforms charge for compounded versions once you factor in their monthly membership fees and shipping costs.

If you're on Medicare and your current Part D plan covers your GLP 1 for diabetes, check whether your plan lists drug on a preferred tier. Switching from a non preferred to a preferred GLP 1 within same class (for example, from Ozempic to Trulicity, or vice versa) can cut your copay in half without your doctor needing to file a new prior authorization. Your plan's formulary is usually searchable online, or your pharmacist can look it up in about 30 seconds.

If none of those paths work and cost is still a barrier, patient assistance programs from both manufacturers accept applications from people below certain income thresholds. These are separate from savings cards and are designed for people who genuinely can't afford drug at any available price point. The application process takes a few weeks, but approval can bring your cost to $0.